))
HER2-low Uncovered: A Phase 1 Retrospective Study on Testing & Concordant Treatment
Manage episode 470085074 series 3599769
Content provided by Ontada Learn. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ontada Learn or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Join us for the conclusion of our 2-part series on HER2-low breast cancer, featuring Dr. Paul Conkling and Dr. Erika Hamilton. They discuss the Phase 1 results from a HER2-low retrospective study evaluating HER2 testing patterns and concordant therapy in patients with HER2 metastatic breast cancer. Learn about the evolving role of HER2-low classification, ongoing education, and treatment strategies to enhance patient outcomes.
Developed and produced by Ontada Learn. The content is intended for educational purposes and reflects current research and expert opinion as of the release date.
13 episodes
Share
